Cardiovascular Disease - Mark M. Holt, MD - Rancho Mirage, CA
Holt Heart Institute - Board Certified Cardiovascular Disease & Nuclear Cardiology
 
                                  Mark Manning Holt, M.D., F.A.C.C.
 
 
CREDENTIALS
Board Certified, National Board of Physicians & Surgeons, Cardiovascular Diseases
Board Certified, Certification Board of Nuclear Cardiology
Medical License, State of California
Unrestricted DEA license
 
 
EDUCATION
Doctor of Medicine, 1998
PONCE SCHOOL OF MEDICINE (U.S. ACCREDITED SCHOOL OF MEDICINE)
Ponce, Puerto Rico
 
 
MEDICAL TRAINING
Fellowship:
Cardiovascular Disease, 2001–2004
THE UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER
Memphis, Tennessee
 
Residency:
Department of Internal Medicine 1999 - 2001
THE UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER
Memphis, Tennessee
 
Internship:
Department of Internal Medicine 1998 - 1999
THE UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER
Memphis, Tennessee
 
 
Hospital Staff Privileges 
Eisenhower Medical Center, Rancho Mirage, California August 2008- Present
 
 
PROFESSIONAL AFFILIATIONS 
Fellow, American College of Cardiology
Coachella Valley Board of Directors, American Heart Association
Member, American Society of Nuclear Cardiology
Member, American Society of Echocardiography
Member, American Medical Association
 
 
AWARDS&ACHIEVEMENTS
The University of Tennessee Health Science Center, Memphis Tennessee
-Achieved outstanding patient satisfaction and excellent clinical outcomes while managing high volume of patients in clinic; maintained one of the lowest mortality rates while overseeing CICU.
 
-Awarded Resident of the Month out of 120 residents for exemplary performance in November 2000.
 
Ponce School of Medicine, (U.S. School of Medicine) Ponce, Puerto Rico
-Achieved academic honors in over 70% of classes/rotations including cardiology consultations with Dr. Mihai Gheorghiade at Northwestern University.
 
-Selected for CICU rotation with Dr. Steven Nissen at Cleveland Clinic in October 1997.
 
-Awarded first place for clinical research leading to extensive use of troponin I and increased accuracy of diagnosing myocardial infarctions at affiliate University hospitals.
 
 
 
GUEST SPEAKER POSITIONS 
Eisenhower Medical Center                Nuclear Stress Imaging          2009
 
 
Novartis Laboratories                         Hypertensive Medications    2009
 
 
Abbott Laboratories                            Cholesterol Medications       2009
 
American Heart Association              AHA Heart Ball Kickoff         2010
 
 
PUBLICATIONS 
MM Holt, Postlethwaite AE, Gerling IC, Weber KT. "Tumor Necrosis Factor-Alpha Production by Human Peripheral Blood Mononuclear Cells. Response to Angiotensin II." Journal of Molecular and Cellular Cardiology. 35:6.2003.
 
 
MM Holt, Postlethwaite AE, Ingels JF, Gerling IC, Weber KT. "Angiotensin II-Induced Modulation of Tumor Necrosis Factor-Alpha Production by Human Peripheral Blood Mononuclear Cells." Journal of Investigative Medicine. 2003
 
 
Cortes, FM; Holt, MM; Mansur, FC.  "Troponin I, Myoglobin, and Creatinine Phosphokinase as Early Markers of Myocardial Necrosis." PRHSJ Abstracts of the XVI Interamerican Congress of Cardiology. 16:50.1997.
 
 
PRESENTATIONS
MM Holt, Postlethwaite AE, Gerling IC, Weber KT. "Tumor Necrosis Factor-Alpha Production by Human Peripheral Blood Mononuclear Cells. Response to Angiotensin II." International Society for Heart Research, Mystic, Connecticut, June2003.
 
 
Holt MM, Postlethwaite AE, Ingels JF, Gerling IC, Weber KT. "Angiotensin II-Induced Modulation of Tumor Necrosis Factor-Alpha Production by Human Peripheral Blood Mononuclear Cells." Southern Section American Federation for Medical Research, New Orleans, Louisiana, February 2003.
 
 
Cortes, FM; Holt, MM; Mansur, FC.  "Troponin I, Myoglobin, and Creatinine Phosphokinase as Early Markers of Myocardial Necrosis." XVI Interamerican Congress of Cardiology, Fajardo, Puerto Rico, September 1997.
 
 
Holt, MM; Mansur, FC. "Troponin I, Myoglobin, and Creatinine Phosphokinase as Early Markers of Myocardial Necrosis." 45 Annual Scientific Meeting, Damas Hospital, Ponce, Puerto Rico, May 1997.